Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675454 · ClinicalTrials.gov registry record
Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 802
- Enrollment target
NCT00675454: Clinical Trial study, sponsored by Washington University School of Medicine.
NCT00675454 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 802 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00675454 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 802 participants
- Enrollment target
Study Summary
Emphysema is a lung disease that involves damage to the air sacs in the lungs and can lead to breathing difficulties. Treatment options for people with emphysema include pulmonary rehabilitation, lung volume reduction surgery, and lung transplantation. This study will observe people with emphysema to assess the effect of these treatment therapies on their quality of life and long-term health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 802 participants |
| Start Date | 2000-01 |
| Est. Completion | 2015-09-11 |
Why NCT00675454 stopped before completion
NCT00675454 is an observational study that tracks outcomes without assigning an intervention. The registered 802 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00675454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00675454 about?
NCT00675454 is a clinical study titled "Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema". Emphysema is a lung disease that involves damage to the air sacs in the lungs and can lead to breathing difficulties. Treatment options for people with emphysema include pulmonary rehabilitation, lung volume reduction surgery, and lung transplantation. This study will observe people with emphysema t...
What is the current status of trial NCT00675454?
This trial is currently terminated. The enrollment target is 802 participants. The study started on 2000-01. Estimated completion is 2015-09-11.
Who is sponsoring clinical trial NCT00675454?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03524430 · 801 participants · NA
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia